MEDPAL AI is trading 6.9% up at £6.20, with no clear catalyst identified.

  • No new company-specific announcement was identified for September 16, 2026.
  • The latest listed RNS was the September 11 warrant exercise; earlier updates included August revenue growth and a board change, neither directly explaining the move.
  • Broader markets were modestly firmer, but available evidence does not establish a clear catalyst.